Drug Profile
Alrestatin
Alternative Names: Alrestatin sodium; AY 22844Latest Information Update: 20 May 1997
Price :
$50
*
At a glance
- Originator Wyeth
- Class
- Mechanism of Action Aldehyde reductase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic complications
Most Recent Events
- 24 Nov 1994 Discontinued-II for Diabetic complications in USA (Unknown route)